Chartboost · case study
Jul 7, 2023 · App & gaming
“LoopMe’s bespoke audience was reported result more likely to reach new patients for major pharmaceutical brand , validated by Crossix”
Title as published by Chartboost. Numbers in the title are withheld until Agora Nova verifies them against the original page.
Reported results are the publisher’s claims. Agora Nova has not verified them.View original case study
Who was involved
Brand
LSLoopMe’s bespoke audienceDetected automaticallyAgency
None namedTechnology
None namedMeasurement
None namedPlatform
- Source
- loopme.ai · Partner Programs: Measurement, CTV, App & Gaming, last checked Oct 20, 2026